N-(Azido-PEG2)-N-Boc-PEG4-NHS ester isolone farnesylate CPPHA is developed for the

CPPHA is developed for the research of central nervous system disorders

InChi: InChI=1S/C42H80NO8P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-42(45)51-40(39-50-52(46

ClH/c1-15-12-5-3-2-4-10(12)11-6-8-14-9-7-13(11)15

the amount of Btk captured by the probe is compared with untreated samples and the extent of Btk bonded is demonstrated to be proportional to CC-292 drug concentration

Smiles: COC1C=C(C=CC=1O)[C@H]1OC[C@@H]2[C@H](OC[C@@H]21)C1C=C(OC)C(=CC=1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

N-(Azido-PEG2)-N-Boc-PEG4-NHS ester isolone farnesylate CPPHA is developed for theN (Azido PEG2) N Boc PEG4 NHS ester is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 2093153 95 6 Molecular Weight: 619. 66 Formula: C26H45N5O12 Chemical Name: 2,5 dioxopyrrolidin 1 yl 1 (13 azido 2,2 dimethyl 4 oxo 3,8,11 trioxa 5 azatridecan 5 yl) 3,6,9,12 tetraoxapentadecan 15 oate Smiles: CC(C)(C)OC(=O)N(CCOCCOCCN=[N+]=[N ])CCOCCOCCOCCOCCC(=O)ON1C(=O)CCC1=O InChiKey: JLYRAESBBJMWBK